A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma

BACKGROUND: To date only a handful of drugs are available for the treatment of melanoma. Among them vemurafenib, a Braf(V600E) specific inhibitor, showed promising results in terms of response rate and increase in median survival time. However, its effectiveness is limited by development of resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhandaru, Madhuri, Ardekani, Gholamreza Safaee, Zhang, Guohong, Martinka, Magdalena, McElwee, Kevin J, Li, Gang, Rotte, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051389/
https://www.ncbi.nlm.nih.gov/pubmed/24893747
http://dx.doi.org/10.1186/1471-2407-14-398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051389/
https://www.ncbi.nlm.nih.gov/pubmed/24893747
http://dx.doi.org/10.1186/1471-2407-14-398

Ejemplares similares